Literature DB >> 3969806

Age- and sex-associated modification of plasma melatonin concentrations in man. Relationship to pathology, malignant or not, and autopsy findings.

Y Touitou, M Fevre-Montange, J Proust, E Klinger, J P Nakache.   

Abstract

Plasma melatonin concentrations were determined in 757 unselected elderly patients aged 80.9 +/- 9.7 years. The daytime (8-9.30 h) plasma levels of melatonin were in the so-called normal range in only one third of the population whereas 65% of the subjects had abnormal levels of the hormone, most often decreased i.e. less than 0.17 nmol/l (53%) and sometimes increased i.e. 0.43 nmol/l or higher (12%). A control group of healthy elderly subjects showed the same distribution as the entire population. A sex-difference with significantly higher levels of plasma melatonin in elderly women was observed. With respect to pathology and autopsy findings high levels of the hormone correlated with cancer, chronic renal failure, cardiovascular disease, biological inflammatory syndrome and diabetes. Low levels correlated with neurologic disease, tobacco or alcohol addiction. However, some of these relations were found to be sex-related as they were observed in women but not in men. Our data indicate that pineal function seems to be often altered in elderly human subjects and suggest potential diagnostic applications of melatonin determination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3969806     DOI: 10.1530/acta.0.1080135

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

1.  Pineal control of aging: effect of melatonin and pineal grafting on aging mice.

Authors:  W Pierpaoli; W Regelson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

2.  Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature.

Authors:  Michelle Basler; Alexander Jetter; Daniel Fink; Burkhardt Seifert; Gerd A Kullak-Ublick; Andreas Trojan
Journal:  Breast Care (Basel)       Date:  2014-07       Impact factor: 2.860

3.  Urine melatonin in alcoholic patients: a marker of alcohol abuse?

Authors:  G Murialdo; U Filippi; P Costelli; S Fonzi; P Bo; A Polleri; F Savoldi
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

4.  Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region.

Authors:  José Leston; Carmine Mottolese; Jacques Champier; Anne Jouvet; Jocelyne Brun; Marc Sindou; Guy Chazot; Bruno Claustrat; Michelle Fèvre-Montange
Journal:  J Neurooncol       Date:  2009-01-25       Impact factor: 4.130

5.  Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction.

Authors:  Leonardo Lorente; María M Martín; Pedro Abreu-González; Antonia Pérez-Cejas; Luis Ramos; Mónica Argueso; Jordi Solé-Violán; Juan J Cáceres; Alejandro Jiménez; Victor García-Marín
Journal:  J Int Med Res       Date:  2018-05-30       Impact factor: 1.671

Review 6.  The Reserve/Maximum Capacity of Melatonin's Synthetic Function for the Potential Dimorphism of Melatonin Production and Its Biological Significance in Mammals.

Authors:  Dun-Xian Tan; Rüdiger Hardeland
Journal:  Molecules       Date:  2021-12-02       Impact factor: 4.411

7.  Melatonin restores zinc levels, activates the Keap1/Nrf2 pathway, and modulates endoplasmic reticular stress and HSP in rats with chronic hepatotoxicity.

Authors:  Silvia Bona; Sabrina Alves Fernandes; Andrea C Janz Moreira; Graziella Rodrigues; Elizângela G Schemitt; Fabio Cangeri Di Naso; Cláudio A Marroni; Norma P Marroni
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-03-05

8.  Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines.

Authors:  Georges Maestroni
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-10       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.